271 related articles for article (PubMed ID: 35550114)
1. Old drugs, new tricks: Emerging role of drug repurposing in the management of atopic dermatitis.
Prasannanjaneyulu V; Nene S; Jain H; Nooreen R; Otavi S; Chitlangya P; Srivastava S
Cytokine Growth Factor Rev; 2022 Jun; 65():12-26. PubMed ID: 35550114
[TBL] [Abstract][Full Text] [Related]
2. Repurposing approved therapeutics for new indication: Addressing unmet needs in psoriasis treatment.
Jain H; Bhat AR; Dalvi H; Godugu C; Singh SB; Srivastava S
Curr Res Pharmacol Drug Discov; 2021; 2():100041. PubMed ID: 34909670
[TBL] [Abstract][Full Text] [Related]
3. Annoying Psoriasis and Atopic Dermatitis: A Narrative Review.
Chen WY; Chen SC; Hsu SY; Lin YA; Shih CM; Huang CY; Wang KH; Lee AW
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563285
[TBL] [Abstract][Full Text] [Related]
4. Can we teach old drugs new tricks?-Repurposing of neuropharmacological drugs for inflammatory skin diseases.
Abels C; Soeberdt M
Exp Dermatol; 2019 Sep; 28(9):1002-1009. PubMed ID: 31173654
[TBL] [Abstract][Full Text] [Related]
5. Selective JAK1 Inhibitors for the Treatment of Atopic Dermatitis: Focus on Upadacitinib and Abrocitinib.
Ferreira S; Guttman-Yassky E; Torres T
Am J Clin Dermatol; 2020 Dec; 21(6):783-798. PubMed ID: 32776305
[TBL] [Abstract][Full Text] [Related]
6. Janus Kinase Inhibitors in Dermatology: Part 2: Applications in Psoriasis, Atopic Dermatitis, and Other Dermatoses.
Garcia-Melendo C; Cubiró X; Puig L
Actas Dermosifiliogr (Engl Ed); 2021; 112(7):586-600. PubMed ID: 34030992
[TBL] [Abstract][Full Text] [Related]
7. Systemic immune mechanisms in atopic dermatitis and psoriasis with implications for treatment.
Guttman-Yassky E; Krueger JG; Lebwohl MG
Exp Dermatol; 2018 Apr; 27(4):409-417. PubMed ID: 28266782
[TBL] [Abstract][Full Text] [Related]
8. Biologics and Small Molecule Agents in Allergic and Immunologic Skin Diseases.
Kaufman BP; Alexis AF
Curr Allergy Asthma Rep; 2018 Aug; 18(10):55. PubMed ID: 30171358
[TBL] [Abstract][Full Text] [Related]
9. Protein tyrosine phosphatase conjugated with a novel transdermal delivery peptide, astrotactin 1-derived peptide recombinant protein tyrosine phosphatase (AP-rPTP), alleviates both atopic dermatitis-like and psoriasis-like dermatitis.
Kim WJ; Koo JH; Cho HJ; Lee JU; Kim JY; Lee HG; Lee S; Kim JH; Oh MS; Suh M; Shin EC; Ko JY; Sohn MH; Choi JM
J Allergy Clin Immunol; 2018 Jan; 141(1):137-151. PubMed ID: 28456618
[TBL] [Abstract][Full Text] [Related]
10. Drug Repurposing for Atopic Dermatitis by Integration of Gene Networking and Genomic Information.
Adikusuma W; Irham LM; Chou WH; Wong HS; Mugiyanto E; Ting J; Perwitasari DA; Chang WP; Chang WC
Front Immunol; 2021; 12():724277. PubMed ID: 34721386
[TBL] [Abstract][Full Text] [Related]
11. JAK-inhibitors in dermatology: current evidence and future applications.
Ciechanowicz P; Rakowska A; Sikora M; Rudnicka L
J Dermatolog Treat; 2019 Nov; 30(7):648-658. PubMed ID: 30433838
[TBL] [Abstract][Full Text] [Related]
12. Innovation in the treatment of atopic dermatitis: Emerging topical and oral Janus kinase inhibitors.
Nakashima C; Yanagihara S; Otsuka A
Allergol Int; 2022 Jan; 71(1):40-46. PubMed ID: 34815171
[TBL] [Abstract][Full Text] [Related]
13. Emerging Treatment Options in Atopic Dermatitis: Topical Therapies.
Nygaard U; Deleuran M; Vestergaard C
Dermatology; 2017; 233(5):333-343. PubMed ID: 29216643
[TBL] [Abstract][Full Text] [Related]
14. Comparison of psoriasis and atopic dermatitis guidelines-an argument for aggressive atopic dermatitis management.
Lohman ME; Lio PA
Pediatr Dermatol; 2017 Nov; 34(6):739-742. PubMed ID: 28944965
[TBL] [Abstract][Full Text] [Related]
15. Cytokine and anti-cytokine therapies for psoriasis and atopic dermatitis.
Numerof RP; Asadullah K
BioDrugs; 2006; 20(2):93-103. PubMed ID: 16626167
[TBL] [Abstract][Full Text] [Related]
16. Therapy of atopic eczema.
Werfel T; Claes C; Kulp W; Greiner W; von der Schulenburg JM
GMS Health Technol Assess; 2006 Oct; 2():Doc19. PubMed ID: 21289970
[TBL] [Abstract][Full Text] [Related]
17. Emerging topical drug delivery approaches for the treatment of Atopic dermatitis.
Ghosalkar S; Singh P; Ravikumar P
J Cosmet Dermatol; 2022 Feb; 21(2):536-549. PubMed ID: 34935274
[TBL] [Abstract][Full Text] [Related]
18. Drug Repurposing Prediction for Immune-Mediated Cutaneous Diseases using a Word-Embedding-Based Machine Learning Approach.
Patrick MT; Raja K; Miller K; Sotzen J; Gudjonsson JE; Elder JT; Tsoi LC
J Invest Dermatol; 2019 Mar; 139(3):683-691. PubMed ID: 30342048
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic management of adults with atopic dermatitis: comparison with psoriasis and chronic urticaria.
Pascal C; Maucort-Boulch D; Gilibert S; Bottigioli D; Verdu V; Jaulent C; Hacard F; Bérard F; Nicolas JF; Nosbaum A
J Eur Acad Dermatol Venereol; 2020 Oct; 34(10):2339-2345. PubMed ID: 32119144
[TBL] [Abstract][Full Text] [Related]
20. "Inflammatory skin march" in atopic dermatitis and psoriasis.
Furue M; Kadono T
Inflamm Res; 2017 Oct; 66(10):833-842. PubMed ID: 28620798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
